Table 4: Association of Laboratory-defined Haemolysis with On-device and 30-day Mortality.
| On-device Mortality | 30-day Mortality | |||
|---|---|---|---|---|
| OR [95% CI] | p-value | OR [95% CI] | p-value | |
| Laboratory haemolysis | 0.605 [0.109–3.357] | 0.565 | 2.181 [0.367–12.952] | 0.391 |
| Origin of cardiogenic shock | 1.288 [0.295–5.628] | 0.736 | 0.821 [0.185–3.638] | 0.794 |
| Emergency Impella insertion | 2.347 [0.315–17.467] | 0.405 | 1.266 [0.212–7.552] | 0.795 |
| Lactic acid prior to device insertion | 1.136 [0.940–1.371] | 0.186 | 1.004 [0.838–1.203] | 0.966 |
| Pulse pressure variation | 1.016 [0.983–1.050] | 0.351 | 1.017 [0.983–1.051] | 0.334 |
| Left ventricular ejection fraction | 0.973 [0.929–1.019] | 0.244 | 0.973 [0.934–1.015] | 0.205 |
Laboratory haemolysis defined as a drop in haemoglobin ≥2 g/dl and either undetectable haptoglobin or lactate dehydrogenase ≥250 units/l (twofold the upper limit of normal).